John Keells Foundation supports funding of a Molecular Virology Laboratory at IDH!

The John Keells Group, through John Keells Foundation and in collaboration with SAGT and Deutsche Bank, contributed to the establishment of a Molecular Virology Laboratory at National Institute of Infectious Diseases (IDH), to increase testing capacity of Sri Lanka. The contribution involved funding of certain equipment and consumables required for the lab to commence operations on an immediate basis.
The temporary facility, which has been set up pending the establishment of a fully equipped lab, became operational from 29th March 2020 to cater to the immediate need of increasing the overall testing capacity of the country and reduce the test turnaround times relating to COVID-19 patients. The establishment of a Molecular Virology Laboratory will also contribute to improve clinical management of patients as it will be possible carry out tests at IDH without sending them to MRI. The Laboratory will also prevent possible biohazards surrounding the disposal and transportation of infectious materials while it will also help in the prompt discharge of individuals who have been tested negative.

John Keells Foundation supports funding of a Molecular Virology Laboratory at IDH!

The John Keells Group, through John Keells Foundation and in collaboration with SAGT and Deutsche Bank, contributed to the establishment of a Molecular Virology Laboratory at National Institute of Infectious Diseases (IDH), to increase testing capacity of Sri Lanka. The contribution involved funding of certain equipment and consumables required for the lab to commence operations on an immediate basis.
The temporary facility, which has been set up pending the establishment of a fully equipped lab, became operational from 29th March 2020 to cater to the immediate need of increasing the overall testing capacity of the country and reduce the test turnaround times relating to COVID-19 patients. The establishment of a Molecular Virology Laboratory will also contribute to improve clinical management of patients as it will be possible carry out tests at IDH without sending them to MRI. The Laboratory will also prevent possible biohazards surrounding the disposal and transportation of infectious materials while it will also help in the prompt discharge of individuals who have been tested negative.

Latest News

John Keells Group’s OCTAVE partners with the University of Colombo in driving Data and Advanced Analytics Education

John Keells Group’s OCTAVE partners with the University of Colombo in driving Data and Advanced Analytics Education

27 August, 2024

JKH records EBITDA of Rs.7.70 billion in Q1 2024/25

JKH records EBITDA of Rs.7.70 billion in Q1 2024/25

30 July, 2024

JKH records strong Q4 2023/24 with recurring EBITDA growth of 20% to Rs.13.97 billion

JKH records strong Q4 2023/24 with recurring EBITDA growth of 20% to Rs.13.97 billion

21 May, 2024

John Keells partners with Sysco LABS Sri Lanka and Brandix Lanka (Pvt) Ltd for the FastTrack summer internship programme 2024.

John Keells partners with Sysco LABS Sri Lanka and Brandix Lanka (Pvt) Ltd for the FastTrack summer internship programme 2024.

14 May, 2024